معرفی
Professor Michael Boyer is a Clinical Professor in Medicine at the University of Sydney's Central Clinical School, affiliated with the Chris O'Brien Lifehouse. His career spans over three decades in medical oncology, with leadership roles including Director of the Sydney Cancer Centre and Head of Medical Oncology at Royal Prince Alfred Hospital. He holds an AM (Member of the Order of Australia) for his contributions to oncology.
Education: Completed a PhD in Cell Biology at the University of Toronto (1990–1993) and specialty training in medical oncology at Royal Prince Alfred and Westmead Hospitals. His expertise includes thoracic malignancies, head and neck cancers, and clinical trials in lung cancer and mesothelioma.
Research focuses on translational oncology, with over 145 publications. Notable contributions include pioneering work in EGFR mutations, PD-L1 biomarkers, and immunotherapy combinations in lung cancer. He chairs the Australasian Lung Cancer Trials Group and serves on the Board of the International Association for the Study of Lung Cancer.
Key awards include the 2010 AM for services to medicine. His clinical trials emphasize novel therapies, including immune checkpoint inhibitors and targeted agents in metastatic disease. He has led studies on aerobic exercise during chemotherapy and telehealth in oncology.
Advising: Supervises research students like Catherine SEET-LEE. Grants and trials include phase I/II studies on novel agents and combination therapies. His work spans institutions like Chris O’Brien Lifehouse, Royal Prince Alfred Hospital, and international collaborations.
Labs/Teams: Active in the Lung Cancer and Thoracic Malignancies research groups, focusing on molecular mechanisms and clinical trial networks.
